ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
13.71
-0.14 (-1.01%)
At close: Mar 6, 2026, 4:00 PM EST
13.51
-0.20 (-1.46%)
After-hours: Mar 6, 2026, 7:56 PM EST
ORIC Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 33.19 | 28.82 | 25.61 | 25.09 | 22.01 | |
| Research & Development | 109.82 | 114.07 | 85.17 | 61.68 | 56.86 | |
| Operating Expenses | 143 | 142.9 | 110.78 | 86.77 | 78.87 | |
| Operating Income | -143 | -142.9 | -110.78 | -86.77 | -78.87 | |
| Interest & Investment Income | 13.54 | 15.05 | 10.08 | 2.65 | 0.14 | |
| Other Non Operating Income (Expenses) | - | - | - | - | 0.02 | |
| EBT Excluding Unusual Items | -129.47 | -127.85 | -100.7 | -84.12 | -78.72 | |
| Pretax Income | -129.47 | -127.85 | -100.7 | -89.12 | -78.72 | |
| Net Income | -129.47 | -127.85 | -100.7 | -89.12 | -78.72 | |
| Net Income to Common | -129.47 | -127.85 | -100.7 | -89.12 | -78.72 | |
| Shares Outstanding (Basic) | 88 | 70 | 51 | 40 | 38 | |
| Shares Outstanding (Diluted) | 88 | 70 | 51 | 40 | 38 | |
| Shares Change (YoY) | 25.91% | 35.52% | 29.74% | 4.48% | 72.97% | |
| EPS (Basic) | -1.47 | -1.83 | -1.96 | -2.25 | -2.07 | |
| EPS (Diluted) | -1.47 | -1.83 | -1.96 | -2.25 | -2.07 | |
| Free Cash Flow | -111.68 | -113.85 | -86.54 | -77.22 | -60.48 | |
| Free Cash Flow Per Share | -1.27 | -1.63 | -1.68 | -1.95 | -1.59 | |
| EBITDA | -141.78 | -141.79 | -109.75 | -85.8 | -77.97 | |
| D&A For EBITDA | 1.22 | 1.11 | 1.03 | 0.97 | 0.9 | |
| EBIT | -143 | -142.9 | -110.78 | -86.77 | -78.87 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.